| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |